The Treaty That Lost Its Way: Why the FCTC Needs Reform, Not Reverence

When the World Health Organisation adopted the Framework Convention on Tobacco Control in 2003, it was hailed as a landmark moment in public health. It was presented as the world’s first global treaty designed to tackle one of humanity’s deadliest preventable causes of disease: smoking.

Its purpose sounded noble enough. Reduce smoking prevalence. Protect future generations. Limit industry influence. Save lives.

More than two decades later, it is worth asking an uncomfortable but necessary question: has the FCTC delivered on its promise?

The answer is complicated. While the treaty succeeded in putting tobacco control on the global agenda, it has increasingly become an inflexible ideological framework that often prioritises orthodoxy over outcomes. It has become a system more concerned with preserving its own doctrine than adapting to emerging evidence.

If the ultimate goal is reducing smoking-related death and disease, then success should be measured by one thing above all else: how many people stop smoking combustible cigarettes.

By that measure, some of the world’s most successful examples of tobacco harm reduction have emerged not because countries strictly followed the FCTC’s ideological playbook, but because they deviated from it.

The treaty’s greatest weakness is not its ambition.

It is its refusal to evolve.

The timing of this reflection is especially significant as the world marks World Vape Day.

Observed each year on May 30, the day before World No Tobacco Day, World Vape Day exists for a reason. It serves as a reminder that millions of former smokers around the world have achieved what decades of traditional tobacco control often failed to deliver: they have left combustible cigarettes behind through access to safer nicotine alternatives.

World Vape Day is not a celebration of nicotine itself.

It is a recognition of progress.

It is a recognition that for countless smokers, vaping has succeeded where abstinence-only approaches have failed. It is a day that gives voice to those whose quit stories are too often ignored by global public health institutions because they do not fit neatly within an ideological narrative.

That silence is telling.

At the very moment when public health should be listening to the lived experiences of people who have escaped smoking through harm reduction, many within the global tobacco control establishment remain uncomfortable even acknowledging their existence.

This discomfort reflects the deeper problem with the FCTC itself.

The treaty was built on a model of tobacco control rooted in abstinence and restriction. Tax cigarettes heavily. Ban advertising. Restrict access. Denormalise smoking through public messaging and regulation.

These measures have contributed to declines in smoking in many countries, particularly high-income nations with strong institutions and enforcement capacity.

But implementation has been wildly uneven.

Many of the treaty’s signatories continue to struggle with high smoking prevalence despite formally endorsing its provisions. In some countries, tobacco advertising remains widespread. Enforcement is weak. Illicit trade flourishes. Public health campaigns lack reach.

The treaty contains no meaningful enforcement mechanism. Nations can endorse their principles publicly while quietly failing to implement them in practice.

The result is a framework that often operates more as symbolic diplomacy than as an effective public health intervention.

Nowhere is this contradiction more obvious than in countries where rigid tobacco control policies coexist with persistent smoking epidemics.

Meanwhile, countries that have embraced pragmatic harm reduction have often achieved what the FCTC merely promises.

Consider Sweden.

Sweden is on track to become the world’s first genuinely smoke-free nation, with adult smoking prevalence below five per cent.

This did not happen through prohibition, punitive messaging, or hostility toward nicotine alternatives.

It happened because Swedish policymakers allowed widespread access to safer alternatives such as snus.

For decades, Swedish smokers were offered a culturally accepted, lower-risk substitute for cigarettes. The result has been dramatic reductions not only in smoking prevalence, but also in smoking-related disease.

Sweden demonstrates a reality that tobacco control orthodoxy often struggles to acknowledge: people do not always need to eliminate nicotine to reduce harm dramatically.

Sometimes they simply need a safer way to consume it.

New Zealand offers another powerful example.

Its embrace of vaping as a smoking cessation tool has coincided with some of the most rapid declines in smoking prevalence seen anywhere in the world.

Rather than framing nicotine alternatives as a threat, New Zealand recognised their potential as a public health opportunity.

It treated adult smokers as people capable of making rational risk-based decisions.

That distinction matters.

Because one of the FCTC’s most consequential failures has been its resistance to harm reduction.

Despite mounting evidence that vaping, nicotine pouches, heated tobacco products, and smokeless alternatives are substantially less harmful than combustible cigarettes, the global tobacco control establishment has often responded with suspicion, hostility, or outright prohibition.

This approach is not evidence-led.

It is ideology-led.

The treaty’s institutional culture has become deeply shaped by a worldview that sees any nicotine use as inherently unacceptable.

Under this logic, the distinction between smoking and vastly lower-risk alternatives becomes blurred.

The public is often presented with messaging that exaggerates uncertainty and minimises relative risk differences.

This has real-world consequences.

When smokers are discouraged from switching to safer alternatives, many simply continue smoking.

That is not a precaution.

That is failure.

We are seeing this dynamic unfold in countries across the world.

In places such as the Maldives, vaping bans have been introduced despite high smoking prevalence and limited access to proven harm reduction alternatives.

These policies may satisfy treaty orthodoxy, but they do little to help smokers transition away from combustible tobacco.

If anything, they entrench cigarette use.

This exposes a deeper contradiction at the heart of the FCTC.

The treaty claims to pursue a smoke-free future, yet often opposes the very innovations most capable of accelerating that transition.

Its defenders frequently invoke Article 5.3, which seeks to shield public health policy from tobacco industry interference.

In principle, this is reasonable.

The tobacco industry’s historical deception warrants vigilance.

But in practice, Article 5.3 has too often been interpreted so rigidly that it discourages open engagement with scientific evidence whenever industry involvement exists, even when that evidence concerns lower-risk alternatives capable of reducing harm.

This creates a dangerous intellectual blind spot.

Science should be evaluated on its merits, not dismissed solely because of its origin.

A mature public health framework should be capable of regulating products robustly while still acknowledging their potential benefits.

Protecting policymaking from industry manipulation does not require rejecting innovation.

It requires transparency, scrutiny, and evidence-based regulation.

The FCTC also frequently overlooks the economic realities facing lower-income nations.

In many countries, tobacco production supports livelihoods, tax revenue, and regional economies.

Yet the treaty often offers simplistic prescriptions without providing realistic transition pathways.

This one-size-fits-all model is disconnected from local contexts.

It assumes every nation can replicate the policy environment of wealthy Western states.

They cannot.

Public health frameworks that ignore economic complexity risk generating resistance, non-compliance, and black-market growth.

Australia offers a cautionary example.

Its increasingly prohibitionist nicotine policies have coincided with the explosive growth of illicit markets, undermining regulatory goals while reducing access to safer alternatives for smokers.

This should serve as a warning to the broader global tobacco control movement.

Restrictive policy without practical alternatives creates unintended consequences.

That is precisely why World Vape Day matters.

It provides a counterbalance to institutional narratives that too often erase consumer voices.

Behind every statistic are real people: parents who switched after decades of smoking, workers who finally found an alternative they could sustain, individuals who regained their health not through coercion, but through choice.

Their stories matter because they expose the gap between lived reality and policy ideology.

Too often, international tobacco control discussions are dominated by institutions speaking about smokers rather than listening to them.

World Vape Day reminds us that effective public health must be grounded in people’s actual experiences.

If global policymakers are serious about ending smoking, they must start paying attention to the millions who have already shown them a path forward.

The FCTC also helped entrench a moralised approach to smoking.

Public messaging has too often drifted beyond education into stigma.

Smokers are frequently portrayed not as individuals managing addiction, but as social problems requiring correction.

This framing is deeply counterproductive.

Addiction is not a moral failure.

People struggling to quit do not need shame.

They need options.

They need accurate information.

They need compassionate support.

Harm reduction offers exactly that.

It recognises the reality that many smokers cannot or will not quit nicotine entirely.

Rather than demanding perfection, it seeks meaningful risk reduction.

That is what real public health should do.

The tragedy is that the FCTC was not destined to become this rigid.

It could still evolve.

It could embrace innovation.

It could incorporate harm reduction into its framework while preserving strong safeguards against corporate misconduct.

It could focus less on ideological purity and more on measurable outcomes.

And perhaps there is no better moment to make that call than on World Vape Day.

Because this day is ultimately about hope.

Hope that public health can rediscover pragmatism.

Hope that science can prevail over dogma.

Hope that the voices of consumers can finally be heard.

It would require humility.

It would require acknowledging that some of the most successful anti-smoking strategies have emerged outside the treaty’s traditional doctrine.

And it would require accepting a difficult truth:

A smoke-free future is unlikely to be achieved through prohibitionist absolutism.

It will be achieved through pragmatism.

Through science.

Through compassion.

And through recognising that reducing harm is not a compromise.

It is progress.

Until the FCTC embraces that reality, it risks becoming less a framework for tobacco control and more a monument to institutional inertia.

A treaty designed to save lives should never become too proud to change course.

And on World Vape Day, that truth deserves to be said louder than ever.